Informatie:
Fout:
ID
32713
Beschrijving
Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis
Trefwoorden
Versies (1)
- 13-11-18 13-11-18 -
Houder van rechten
GSK group of companies
Geüploaded op
13 november 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Estimation of Dose Proportionality of Darapladib - 107038
PGx-Pharmacogenetic Research Consent
- StudyEvent: ODM
Similar models
PGx-Pharmacogenetic Research Consent
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
PGx-Pharmacogenetic Research Consent Question
Has Informed consent been obtained for PGx-Pharmacogenetic research?
Item
Has Informed consent been obtained for PGx-Pharmacogenetic research?
boolean
If YES, record Date informed consent obtained for PGx-Pharmacogenetic research
Item
If YES, record Date informed consent obtained for PGx-Pharmacogenetic research
date
CL Item
Subject declined (1)
CL Item
Subject not asked by Investigator (2)
CL Item
Other (3)
If OTHER, specify
Item
If OTHER, specify
text
Has a blood sample been collected for PGx-pharmacogenetic research?
Item
Has a blood sample been collected for PGx-pharmacogenetic research?
boolean
If YES, record date sample taken
Item
If YES, record date sample taken
boolean